104 related articles for article (PubMed ID: 9163685)
1. Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16alpha-fluoro-5-androsten-17-one.
Perkins SN; Hursting SD; Haines DC; James SJ; Miller BJ; Phang JM
Carcinogenesis; 1997 May; 18(5):989-94. PubMed ID: 9163685
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the enhancing effects of dehydroepiandrosterone with the structural analog 16 alpha-fluoro-5-androsten-17-one on aflatoxin B1 hepatocarcinogenesis in rainbow trout.
Orner GA; Donohoe RM; Hendricks JD; Curtis LR; Williams DE
Fundam Appl Toxicol; 1996 Nov; 34(1):132-40. PubMed ID: 8937900
[TBL] [Abstract][Full Text] [Related]
3. p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages.
Mei JJ; Hursting SD; Perkins SN; Phang JM
Cancer Lett; 1998 Jul; 129(2):191-7. PubMed ID: 9719461
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone.
McCormick DL; Johnson WD; Kozub NM; Rao KV; Lubet RA; Steele VE; Bosland MC
Carcinogenesis; 2007 Feb; 28(2):398-403. PubMed ID: 16952912
[TBL] [Abstract][Full Text] [Related]
5. Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomes.
Schwartz AG; Pashko LL
Cancer Lett; 2001 Jul; 168(1):7-14. PubMed ID: 11368871
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides.
Pashko LL; Lewbart ML; Schwartz AG
Carcinogenesis; 1991 Nov; 12(11):2189-92. PubMed ID: 1934309
[TBL] [Abstract][Full Text] [Related]
7. Food intake reduction and immunologic alterations in mice fed dehydroepiandrosterone.
Weindruch R; McFeeters G; Walford RL
Exp Gerontol; 1984; 19(5):297-304. PubMed ID: 6239786
[TBL] [Abstract][Full Text] [Related]
8. Dietary dehydroepiandrosterone inhibits bone marrow and leukemia cell transplants: role of food restriction.
Catalina F; Milewich L; Kumar V; Bennett M
Exp Biol Med (Maywood); 2003 Dec; 228(11):1303-20. PubMed ID: 14681546
[TBL] [Abstract][Full Text] [Related]
9. Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side effects in mice and rats.
Schwartz AG; Lewbart ML; Pashko LL
Cancer Res; 1988 Sep; 48(17):4817-22. PubMed ID: 2970293
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone and its derivatives: potentially novel anti-proliferative and chemopreventive agents.
Matsuzaki Y; Honda A
Curr Pharm Des; 2006; 12(26):3411-21. PubMed ID: 17017935
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of spontaneous tumorigenesis in p53-knockout mice.
Hursting SD; Perkins SN; Haines DC; Ward JM; Phang JM
Cancer Res; 1995 Sep; 55(18):3949-53. PubMed ID: 7664260
[TBL] [Abstract][Full Text] [Related]
13. Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.
Gordon GB; Shantz LM; Talalay P
Adv Enzyme Regul; 1987; 26():355-82. PubMed ID: 2960133
[TBL] [Abstract][Full Text] [Related]
14. Antihyperglycemic effect of dehydroepiandrosterone analogue 16 alpha-fluoro-5-androsten-17-one in diabetic mice.
Pashko LL; Schwartz AG
Diabetes; 1993 Aug; 42(8):1105-8. PubMed ID: 8325440
[TBL] [Abstract][Full Text] [Related]
15. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator.
Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA
Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication.
Henderson E; Yang JY; Schwartz A
AIDS Res Hum Retroviruses; 1992 May; 8(5):625-31. PubMed ID: 1381206
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 7,12-dimethylbenz[a]anthracene-initiated and 12-O-tetradecanoylphorbol-13-acetate-promoted skin papilloma formation in mice by dehydroepiandrosterone and two synthetic analogs.
Schwartz AG; Fairman DK; Polansky M; Lewbart ML; Pashko LL
Carcinogenesis; 1989 Oct; 10(10):1809-13. PubMed ID: 2529051
[TBL] [Abstract][Full Text] [Related]
18. Induction of ovarian granulosa cell tumors in SWXJ-9 mice with dehydroepiandrosterone.
Beamer WG; Shultz KL; Tennent BJ
Cancer Res; 1988 May; 48(10):2788-92. PubMed ID: 2965969
[TBL] [Abstract][Full Text] [Related]
19. Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs.
Schwartz AG; Pashko LL
J Cell Biochem Suppl; 1993; 17G():73-9. PubMed ID: 8007713
[TBL] [Abstract][Full Text] [Related]
20. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs.
Schwartz AG; Pashko LL
J Cell Biochem Suppl; 1995; 22():210-7. PubMed ID: 8538200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
